Investigation of long non-coding RNAs in extracellular vesicles from low-volume blood serum specimens of colorectal cancer patients

Marie Boudna,Tana Machackova,Petra Vychytilova-Faltejskova,Karolina Trachtova,Renata Bartosova,Tina Catela Ivkovic,Dagmar Al Tukmachi,Robin Jugas,Lucie Pifkova,Jana Orlickova,Jan Kotoucek,Marketa Pavlikova,Milana Sachlova,Lucia Bohovicova,Teodor Stanek,Jana Halamkova,Igor Kiss,Tomas Grolich,Martin Svoboda,Zdenek Kala,Kamila Souckova,Ondrej Slaby
DOI: https://doi.org/10.1007/s10238-024-01323-1
IF: 4.6
2024-04-04
Clinical and Experimental Medicine
Abstract:Colorectal cancer (CRC) is the second most prevalent cancer type worldwide, which highlights the urgent need for non-invasive biomarkers for its early detection and improved prognosis. We aimed to investigate the patterns of long non-coding RNAs (lncRNAs) in small extracellular vesicles (sEVs) collected from low-volume blood serum specimens of CRC patients, focusing on their potential as diagnostic biomarkers. Our research comprised two phases: an initial exploratory phase involving RNA sequencing of sEVs from 76 CRC patients and 29 healthy controls, and a subsequent validation phase with a larger cohort of 159 CRC patients and 138 healthy controls. Techniques such as dynamic light scattering, transmission electron microscopy, and Western blotting were utilized for sEV characterization. Optimized protocol for sEV purification, RNA isolation and preamplification was applied to successfully sequence the RNA content of sEVs and validate the results by RT-qPCR. We successfully isolated sEVs from blood serum and prepared sequencing libraries from a low amount of RNA. High-throughput sequencing identified differential levels of 460 transcripts between CRC patients and healthy controls, including mRNAs, lncRNAs, and pseudogenes, with approximately 20% being lncRNAs, highlighting several tumor-specific lncRNAs that have not been associated with CRC development and progression. The validation phase confirmed the upregulation of three lncRNAs ( NALT1 , AL096828 , and LINC01637 ) in blood serum of CRC patients. This study not only identified lncRNA profiles in a population of sEVs from low-volume blood serum specimens of CRC patients but also highlights the value of innovative techniques in biomolecular research, particularly for the detection and analysis of low-abundance biomolecules in clinical samples. The identification of specific lncRNAs associated with CRC provides a foundation for future research into their functional roles in cancer development and potential clinical applications.
medicine, research & experimental
What problem does this paper attempt to address?
### Problems the paper attempts to solve This paper aims to explore the patterns of long non - coding RNAs (lncRNAs) in small extracellular vesicles (sEVs) in low - volume serum samples of patients with colorectal cancer (CRC), especially the potential of these lncRNAs as diagnostic markers. Specifically, the research is divided into two stages: 1. **Exploration stage**: - Through RNA sequencing of sEVs from 76 CRC patients and 29 healthy control groups, differentially expressed lncRNAs were initially identified. - Techniques such as Dynamic Light Scattering (DLS), Transmission Electron Microscopy (TEM) and Western blotting were used to characterize sEVs. 2. **Validation stage**: - In a larger cohort (159 CRC patients and 138 healthy control groups), the differentially expressed lncRNAs discovered in the exploration stage were verified by real - time quantitative PCR (RT - qPCR). - The protocols for sEVs purification, RNA extraction and pre - amplification were optimized, and sequencing libraries were successfully prepared from a small amount of RNA. Through high - throughput sequencing, 460 transcripts differentially expressed between CRC patients and healthy control groups were identified, of which approximately 20% were lncRNAs. ### Main findings - **Differential expression of lncRNAs**: - High - throughput sequencing results showed that 460 transcripts were significantly different between CRC patients and healthy control groups, including mRNAs, lncRNAs and pseudogenes. - In the validation stage, three lncRNAs (NALT1, AL096828 and LINC01637) were confirmed to be up - regulated in the serum of CRC patients. - **Potential clinical applications**: - This study not only identified the lncRNA profiles of sEVs in low - volume serum samples of CRC patients, but also highlighted the value of innovative technologies in biomolecular research, especially in the detection and analysis of low - abundance biomarkers in clinical samples. - The correlation between specific lncRNAs and CRC provides a basis for future research on their functional roles in cancer development and potential clinical applications. ### Conclusion This study systematically analyzed lncRNAs in sEVs of CRC patients and healthy control groups and discovered several lncRNAs that may serve as early - diagnosis markers. These findings provide new ideas and methods for non - invasive CRC detection.